A recent study found that automated red blood cell exchange (aRBCX) can greatly improve the quality of life for people with sickle cell disease (SCD). The study reviewed over 20 years of data and showed that aRBCX helps reduce hospital stays, pain-related hospital visits, and procedure times, making it a promising treatment option for SCD.
